Next Article in Journal
Regulation of RhoB Gene Expression during Tumorigenesis and Aging Process and Its Potential Applications in These Processes
Next Article in Special Issue
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
Previous Article in Journal
Atypical Histiocytoid Cells and Multinucleated Giant Cells in Fine-Needle Aspiration Cytology of the Thyroid Predict Lymph Node Metastasis of Papillary Thyroid Carcinoma
Previous Article in Special Issue
Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

Department of Medical Oncology, Institut Curie, 75005 Paris, France
Department of Medical Oncology, Catalan Cancer Institute, IDIBELL, CIBERONC, Hospitalet de Llobregat, 08908 Barcelona, Spain
Department of Dermatology, University Hospital Würzburg, 97080 Würzburg, Germany
European Patient Advocacy Group: Melanoma Patient Network Europe & OcuMel, Birmingham B13 8ET, UK
Department of Melanoma, Maria Skłodowska Curie Institute-Oncology Centre, 02-034 Warsaw, Poland
Translational Skin Cancer Research, University of Essen-Duisburg, German Cancer Consortium (DKTK), 47057 Duisburg, Germany
Department of Oncology and FICAN West Cancer Center, Turku University Hospital, 20521 Turku, Finland
Department of Ophthalmology, UZ Leuven, 3000 Leuven, Belgium
Department of Ophthalmology, Università degli Studi di Siena UNISI, 53100 Siena, Italy
Onco-Ophthalmology National Reference Centre, CHUC, 3075 Coimbra, Portugal
Department of Ophthalmololgy, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
EURACAn coordination team, Centre Léon Bérard, 69008 Lyon, France
EURACAN network coordinator, Department of Medical Oncology, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69100 Villeurbanne, France
Department of Medical Oncology, LUMC, 2333 ZA Leiden, the Netherlands
Author to whom correspondence should be addressed.
Cancers 2019, 11(6), 817;
Received: 20 May 2019 / Revised: 7 June 2019 / Accepted: 10 June 2019 / Published: 13 June 2019
(This article belongs to the Special Issue Uveal Melanoma)
Uveal melanoma (UM) is the most frequent primary ocular cancer in adults, accounting for 5% of all melanomas. Despite effective treatments for the primary tumour, up to 50% of UM patients will develop metastasis, leading to a very poor prognosis and a median overall survival of 6 to 12 months, with no major improvements in the last 30 years. There is no standard oncological treatment available for metastatic UM patients, and BRAF/MEK and immune checkpoint inhibitors show disappointing results when compared to cutaneous melanoma (CM). Recent advances in biology, however, identified specific gene and chromosome alterations, potentially permitting an actively tailored surveillance strategy, and dedicated clinical studies. Being a rare cancer, UM patients have to overcome issues such as identifying referral centres, having access to information, and partnering with oncologists for specific management strategies and research priorities. Here, we describe how the European Rare Adult solid Cancer Network (EURACAN) will help in addressing these challenges and accelerating international collaborations to enhance the development of innovative treatments in UM. View Full-Text
Keywords: uveal melanoma; rare cancer; European Reference Network uveal melanoma; rare cancer; European Reference Network
Show Figures

Figure 1

MDPI and ACS Style

Piperno-Neumann, S.; Piulats, J.M.; Goebeler, M.; Galloway, I.; Lugowska, I.; Becker, J.C.; Vihinen, P.; Van Calster, J.; Hadjistilianou, T.; Proença, R.; Caminal, J.M.; Rogasik, M.; Blay, J.-Y.; Kapiteijn, E. Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer. Cancers 2019, 11, 817.

AMA Style

Piperno-Neumann S, Piulats JM, Goebeler M, Galloway I, Lugowska I, Becker JC, Vihinen P, Van Calster J, Hadjistilianou T, Proença R, Caminal JM, Rogasik M, Blay J-Y, Kapiteijn E. Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer. Cancers. 2019; 11(6):817.

Chicago/Turabian Style

Piperno-Neumann, Sophie, Jose M. Piulats, Matthias Goebeler, Iain Galloway, Iwona Lugowska, Jürgen C. Becker, Pia Vihinen, Joachim Van Calster, Theodora Hadjistilianou, Rui Proença, Jose M. Caminal, Muriel Rogasik, Jean-Yves Blay, and Ellen Kapiteijn. 2019. "Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer" Cancers 11, no. 6: 817.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop